GH Research PLC (GHRS)
11.08
-0.22
(-1.95%)
USD |
NASDAQ |
Apr 24, 16:00
11.02
-0.06
(-0.50%)
After-Hours: 20:00
GH Research Total Liabilities (Quarterly): 7.332M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 7.332M |
| September 30, 2023 | 6.795M |
| June 30, 2023 | 7.289M |
| March 31, 2023 | 7.429M |
| December 31, 2022 | 4.546M |
| September 30, 2022 | 3.385M |
| June 30, 2022 | 3.095M |
| Date | Value |
|---|---|
| March 31, 2022 | 4.066M |
| December 31, 2021 | 2.749M |
| September 30, 2021 | 2.033M |
| June 30, 2021 | 4.592M |
| March 31, 2021 | 1.241M |
| December 31, 2020 | 0.246M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
0.246M
Minimum
Dec 2020
7.429M
Maximum
Mar 2023
4.215M
Average
4.066M
Median
Mar 2022
Total Liabilities (Quarterly) Benchmarks
| Amarin Corp PLC | 279.59M |
| Jazz Pharmaceuticals PLC | 7.656B |
| Prothena Corp PLC | 135.02M |
| Iterum Therapeutics PLC | 32.66M |
| Mural Oncology PLC | 37.93M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 226.30M |
| Shareholders Equity (Quarterly) | 218.97M |